Convalescent Plasma Therapy in Severe COVID-19 Patients: Retrospective Study
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 1 | Views: 328 | Monthly Hits: ⮙1

Research Paper | Medical Science | Indonesia | Volume 10 Issue 8, August 2021 | Popularity: 4.9 / 10


     

Convalescent Plasma Therapy in Severe COVID-19 Patients: Retrospective Study

Yeodi Utomo, Wayan Wahyu Semara Putra, Ni Made Dwita Yaniswari


Abstract: Background: Covid-19 is infectious disease that caused by SARS-COV2 Virus. There is no definitive treatment for Covid-19 until now. Convalescent plasma therapy is one of therapy that considered to provide good outcome for Covid-19 patient.In developing country, convalescent plasma is difficult to obtain because there are requirements for donors. There is a time gap between patient?s admission day and first day convalescent plasma administered to patient. The purpose of this article is to explore the association betweentiming of convalescent plasma therapy with outcome in severe covid-19 patient. Method: This study is retrospective study using secondary data of patient?s medical record at Wangaya Hospital, Denpasar, between September 2020 and March 2021. Inclusion criteria is set in this study, include severe Covid-19 patient that had administered convalescent plasma therapy. Result: 32 sample was obtained in this study. Data was analyzed with Kolmogorov smirnov normality test, results is not normally distributed (p=0.003). Fisher exact analysis was performed. We found that there is no significant difference in outcome in severe Covid-19 patient that was given convalescent plasma before and after 3 days admission to hospital (p=1.000, CI 95%). We also found that there is no significant difference in outcome in severe Covid-19 patient that was given convalescent plasma before and after 5 days admission to hospital (p=1.000, CI 95%). Conclusion: There is no significant difference between timing of convalescent plasma therapy and outcome in severe Covid-19 patient. However, further research are needed to explain the effect of convalescent plasma therapy in severe Covid-19 patient.


Keywords: Convalescent plasma therapy, COVID-19, SARS-Cov2


Edition: Volume 10 Issue 8, August 2021


Pages: 105 - 107


DOI: https://www.doi.org/10.21275/SR21731125334



Make Sure to Disable the Pop-Up Blocker of Web Browser


Text copied to Clipboard!
Yeodi Utomo, Wayan Wahyu Semara Putra, Ni Made Dwita Yaniswari, "Convalescent Plasma Therapy in Severe COVID-19 Patients: Retrospective Study", International Journal of Science and Research (IJSR), Volume 10 Issue 8, August 2021, pp. 105-107, https://www.ijsr.net/getabstract.php?paperid=SR21731125334, DOI: https://www.doi.org/10.21275/SR21731125334

Similar Articles

Downloads: 0

Research Paper, Medical Science, Indonesia, Volume 11 Issue 4, April 2022

Pages: 1320 - 1323

Characteristic ARDS with COVID-19

Herani Mutia Riandini, Fajrinur Syarani, Syamsul Bihar, Putri C Eyanoer

Share this Article

Downloads: 0

Review Papers, Medical Science, Indonesia, Volume 11 Issue 5, May 2022

Pages: 672 - 674

Chest Physical Exercise in COVID-19 Patients: A Review Article

Pradivo Luigi Akbar, Edrik Sinawang

Share this Article

Downloads: 170 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper, Medical Science, India, Volume 9 Issue 6, June 2020

Pages: 1634 - 1636

Novel Corona Virus and its Social & Economical Impact on Healthcare Professionals in India

Maj Dr Purushottam Chaudhari, Swati Rai, Dr A Hanan

Share this Article

Downloads: 254 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2

Informative Article, Medical Science, India, Volume 9 Issue 3, March 2020

Pages: 1584 - 1588

Targeting Cytokine Storm for Therapeutic Benefit in COVID19 Patients

Dr. Dileepraja Yedla

Share this Article

Downloads: 260 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2

Research Paper, Medical Science, India, Volume 9 Issue 5, May 2020

Pages: 79 - 87

The Efficiency and Pharmacokinetics of DBore-Covidesivir for the Treatment of COVID-19 Virus Infection; Proved as Theoretical and Structural Pattern

Dronadula Borraiah

Share this Article
Top